US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

CURAD Alcohol Prep Pads

Reason Subpotent Drug

MEDLINE INDUSTRIES, LP - Northfield NDC 53329-827-30 D-0289-2025
Class II · Moderate risk Ongoing

Medline Alcohol Prep Pads

Reason Subpotent Drug

MEDLINE INDUSTRIES, LP - Northfield NDC 53329-811-30 D-0288-2025
Class II · Moderate risk Ongoing

Morphine Sulfate 5 mg per 0.25 mL Oral Syringe

Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Safecor Health, LLC D-0254-2025
Class II · Moderate risk Ongoing

Lorazepam 0.5 mg per 0.25 mL Oral Syringe

Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Safecor Health, LLC D-0253-2025
Class II · Moderate risk Ongoing

Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe

Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Safecor Health, LLC D-0252-2025
Class II · Moderate risk Ongoing

Simethicone 20 mg per 0.3 mL Oral Syringe

Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Safecor Health, LLC D-0251-2025
Class II · Moderate risk Ongoing

Ergocalciferol - Vitamin D Supplement - 10 mcg

Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Safecor Health, LLC D-0250-2025
Class II · Moderate risk Ongoing

Iodo Blanco Iodides

Reason Defective Container: broken or leaking bottles.

World Perfumes Inc. D-0622-2025
Class II · Moderate risk Ongoing

Nelarabine Injection

Reason Failed Impurities/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 70710-1839-1 D-0256-2025
Class II · Moderate risk Ongoing

Nelarabine Injection

Reason Failed Impurities/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 70710-1726-1 D-0255-2025
Class II · Moderate risk Ongoing

ViaMed Alcohol Prep Pads

Reason Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.

Wuxi Medical lnstrument Factory Co., Ltd. D-0247-2025
Class II · Moderate risk Terminated

Sodium Chloride Injection 9%

Reason Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

Nephron Sterile Compounding Center LLC D-0257-2025
Class II · Moderate risk Completed

Estradiol Gel

Reason Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

Padagis US LLC D-0246-2025
Class II · Moderate risk Ongoing

Silodosin Capsules

Reason Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)

AvKARE NDC 42291-778-90 D-0229-2025
Class II · Moderate risk Ongoing

Ciprofloxacin Ophth Solution

Reason Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Direct Rx NDC 61919-795-05 D-0364-2025